ERBB2 and breast carcinoma: IL-21 remarkably enhances IFN-γ secretion from NK cells when cocultured with trastuzumab-coated human breast cancer cells in vitro and enhances the antitumor effect of anti-HER2 monoclonal antibodies in a mouse tumor model 158.